PoLA/CFPiP/PCS guidelines for the management of dyslipidaemias for family physicians 2016
Open accessAbstract
Dyslipidaemias are the most common yet the least well-controlled risk factor for cardiovascular disease (CVD) in Poland [1]. The main modifiable risk factors for atherosclerosis and its complications including ischaemic heart disease (IHD), stroke and peripheral artery disease (PAD) are: smoking, type 2 diabetes, arterial hypertension, inappropriate diet and eating habits, inadequate physical activity as well as the resulting overweight and obesity [6]. As shown by epidemiological studies conducted in Poland, there is a nationwide growth in the above risk factors (with the exception of smoking in the majority of age groups), which is attributable to the increasing prevalence of poor eating habits and sedentary lifestyle [1]. The elimination of risk factors represents one of the greatest challenges to be faced in the domain of public health. In order to rise to up to the challenge, wide-ranging population prevention measures are needed. However, family physicians as well as other health professionals (cardiologists, internists) have a special responsibility towards high-risk patients. The group definitely comprises a considerable proportion of dyslipidaemia patients. Consequently, dyslipidaemia management should be an element of a broader strategy targeted at lowering total CV risk and, hence, reducing mortality, morbidity and disability associated with CVD.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Statin therapy lowers plasma cholesterol and high-sensitivity C-reactive protein, and this is directly associated with improved cardiovascular risk.
“Statin therapy can reduce plasma cholesterol (3,5) and high-sensitivity C-reactive protein levels, and this is directly associated with a significant improvement in CV risk (1,2,6,149,150).”
From The Role of Nutraceuticals in Statin Intolerant Patients (2018) · cites this paper as [2]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Ahmed, A., Jorna, T., & Bhandari, S. (2016) · The Nephron journals/Nephron journals · doi:10.1159/000447068 · Cited by 11,782 · see citing works
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
Authors/Task Force Members:, Perk, J., De Backer, G., Gohlke, H., Graham, I., Reiner, Ž., Verschuren, M., Albus, C., Benlian, P., Boysen, G., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs092 · Cited by 8,490 · see citing works
Self-citationStone, N. J., Robinson, J. G., Lichtenstein, A. H., Bairey Merz, C. N., Blum, C. B., Eckel, R. H., Goldberg, A. C., Gordon, D., Levy, D., Lloyd-Jones, D. M., et al. (2014) · Circulation · doi:10.1161/01.cir.0000437738.63853.7a · Cited by 7,081 · see citing works
Cholesterol Treatment Trialists' (CTT) Collaboration (2010) · The Lancet · doi:10.1016/s0140-6736(10)61350-5 · Cited by 6,550 · see citing works
2016 European Guidelines on cardiovascular disease prevention in clinical practice
Piepoli, M. F., Hoes, A. W., Agewall, S., Albus, C., Brotons, C., Catapano, A. L., Cooney, M.-T., Corrà, U., Cosyns, B., Deaton, C., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw106 · Cited by 6,457 · see citing works
Self-citationEzetimibe Added to Statin Therapy after Acute Coronary Syndromes
Cannon, C. P., Blazing, M. A., Giugliano, R. P., McCagg, A., White, J. A., Theroux, P., Darius, H., Lewis, B. S., Ophuis, T. O., Jukema, J. W., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1410489 · Cited by 4,487 · see citing works
European guidelines on cardiovascular disease prevention in clinical practice: executive summary
Graham, I., Atar, D., Borch‐Johnsen, K., Boysen, G., Burell, G. K., Cífková, R., Dallongeville, J., Backer, G. D., Ebrahim, S. B. J., Gjelsvik, B., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm316 · Cited by 3,840 · see citing works
Colhoun, H. M., Betteridge, D. J., Durrington, P. N., Hitman, G. A., W Neil, H. A., Livingstone, S. J., Thomason, M. J., Mackness, M. I., Charlton-Menys, V., & Fuller, J. H. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16895-5 · Cited by 3,755 · see citing works
ESC/EAS Guidelines for the management of dyslipidaemias
Reiner, Ž., Catapano, A. L., De Backer, G., Graham, I., Taskinen, M.-R., Wiklund, O., Agewall, S., Alegria, E., Chapman, M. J., Durrington, P., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr158 · Cited by 3,549 · see citing works
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
Catapano, A. L., Graham, I., De Backer, G., Wiklund, O., Chapman, M. J., Drexel, H., Hoes, A. W., Jennings, C. S., Landmesser, U., Pedersen, T. R., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw272 · Cited by 3,162 · see citing works
Mutations in PCSK9 cause autosomal dominant hypercholesterolemia
Abifadel, M., Varret, M., Rabès, J.-P., Allard, D., Ouguerram, K., Devillers, M., Cruaud, C., Benjannet, S., Wickham, L., Erlich, D., et al. (2003) · Nature Genetics · doi:10.1038/ng1161 · Cited by 2,985 · see citing works
Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy
The AIM-HIGH Investigators (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1107579 · Cited by 2,911 · see citing works
Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
(2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001282 · Cited by 2,837 · cited 2× · see citing works
“Large clinical trials on fenofibrate conducted in diabetic patients (FIELD – Fenofibrate Intervention and Event Lowering in Diabetes, and ACCORD – Action to Control Cardiovascular Risk in Diabetes) randomized for fenofibrate treatment have failed to demonstrate any effect on CV risk compared to placebo [50, 51].”
BackgroundGersh, B. (2011) · Yearbook of Medicine · doi:10.1016/s0084-3873(11)00278-1 · Cited by 2,768 · see citing works
Nordestgaard, B. G., Chapman, M. J., Humphries, S. E., Ginsberg, H. N., Masana, L., Descamps, O. S., Wiklund, O., Hegele, R. A., Raal, F. J., Defesche, J. C., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht273 · Cited by 2,761 · see citing works
Major lipids, apolipoproteins, and risk of vascular disease
The Emerging Risk Factors Collaboration* (2009) · JAMA · doi:10.1001/jama.2009.1619 · Cited by 2,731 · see citing works
Baigent, C., Landray, M. J., Reith, C., Emberson, J., Wheeler, D. C., Tomson, C., Wanner, C., Krane, V., Cass, A., Craig, J., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60739-3 · Cited by 2,479 · see citing works
Collaborators, C. T. T. (. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60104-x · Cited by 2,081 · see citing works
Statins for the primary prevention of cardiovascular disease
Taylor, F., Huffman, M. D., Macedo, A. F., Moore, T. H., Burke, M., Davey Smith, G., Ward, K., Ebrahim, S., & Gay, H. C. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004816.pub5 · Cited by 1,934 · see citing works
Effects of extended-release niacin with laropiprant in high-risk patients
The HPS2-THRIVE Collaborative Group (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1300955 · Cited by 1,668 · cited 2× · see citing works
“Similarly, HPS2-THRIVE has not found any additional clinical benefit of a treatment based on extended-release niacin with laropiprant (a compound inhibiting the synthesis of prostaglandin D2 which is responsible for skin redness and hot flushes) in combination with a statin [77].”
BackgroundResultRosuvastatin in older patients with systolic heart failure
Kjekshus, J., Apetrei, E., Barrios, V., Böhm, M., Cleland, J. G. F., Cornel, J. H., Dunselman, P., Fonseca, C., Goudev, A., Grande, P., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa0706201 · Cited by 1,487 · see citing works
Stroes, E. S., Thompson, P. D., Corsini, A., Vladutiu, G. D., Raal, F. J., Ray, K. K., Roden, M., Stein, E., Tokgözoğlu, L., Nordestgaard, B. G., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv043 · Cited by 1,443 · see citing works
Jones, P. H., Davidson, M. H., Stein, E. A., Bays, H. E., McKenney, J. M., Miller, E., Cain, V. A., & Blasetto, J. W. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(03)00530-7 · Cited by 1,392 · see citing works
Toth, P. (2012) · Yearbook of Endocrinology · doi:10.1016/j.yend.2012.05.035 · Cited by 1,362 · see citing works
Peters, M. J. L., Symmons, D. P. M., McCarey, D., Dijkmans, B. A. C., Nicola, P., Kvien, T. K., McInnes, I. B., Haentzschel, H., Gonzalez-Gay, M. A., Provan, S., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.113696 · Cited by 1,325 · see citing works
Simvastatin with or without Ezetimibe in Familial Hypercholesterolemia
Kastelein, J. J. P., Akdim, F., Stroes, E. S. G., Zwinderman, A. H., Bots, M. L., Stalenhoef, A. F. H., Visseren, F. L. J., Sijbrands, E. J. G., Trip, M. D., Stein, E. A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0800742 · Cited by 1,241 · see citing works
Chapman, M. J., Ginsberg, H. N., Amarenco, P., Andreotti, F., Borén, J., Catapano, A. L., Descamps, O. S., Fisher, E., Kovanen, P. T., Kuivenhoven, J. A., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr112 · Cited by 1,227 · see citing works
GISSI-HF investigators (2008) · The Lancet · doi:10.1016/s0140-6736(08)61240-4 · Cited by 1,106 · see citing works
Cuchel, M., Bruckert, E., Ginsberg, H. N., Raal, F. J., Santos, R. D., Hegele, R. A., Kuivenhoven, J. A., Nordestgaard, B. G., Descamps, O. S., Steinhagen-Thiessen, E., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu274 · Cited by 1,057 · see citing works
Martin, S. S., Blaha, M. J., Elshazly, M. B., Toth, P. P., Kwiterovich, P. O., Blumenthal, R. S., & Jones, S. R. (2013) · JAMA · doi:10.1001/jama.2013.280532 · Cited by 883 · see citing works
Brugts, J. J., Yetgin, T., Hoeks, S. E., Gotto, A. M., Shepherd, J., Westendorp, R. G. J., de Craen, A. J. M., Knopp, R. H., Nakamura, H., Ridker, P., et al. (2009) · BMJ · doi:10.1136/bmj.b2376 · Cited by 792 · see citing works
The target of ezetimibe is Niemann-Pick C1-Like 1 (NPC1L1)
Garcia-Calvo, M. M., Lisnock, J., Bull, H. G., Hawes, B. E., Burnett, D. A., Braun, M. P., Crona, J. H., Davis, H. R., Dean, D. C., Detmers, P. A., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500269102 · Cited by 770 · see citing works
Gidding, S. S., Ann Champagne, M., de Ferranti, S. D., Defesche, J., Ito, M. K., Knowles, J. W., McCrindle, B., Raal, F., Rader, D., Santos, R. D., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000297 · Cited by 723 · see citing works
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
Perk, J., Backer, G. D., Gohlke, H., Graham, I. M., Reiner, Ž., Verschuren, W. M. M., Albus, C., Benlian, P., Boysen, G., Cífková, R., et al. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.05.007 · Cited by 693 · see citing works
Amarenco, P., & Labreuche, J. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70058-4 · Cited by 660 · see citing works
Wanner, C., the Kidney Disease: Improving Global Outcomes Lipid Guideline Development Work Group Members, & Tonelli, M. (2014) · Kidney International · doi:10.1038/ki.2014.31 · Cited by 649 · cited 2× · see citing works
“The decision should depend on the evaluation of total cardiovascular risk taking into account the patient’s age, and the degree of kidney failure and/or estimated glomerular filtration rate (eGFR) [127, 128].”
BackgroundHegele, R. A., Ginsberg, H. N., Chapman, M. J., Nordestgaard, B. G., Kuivenhoven, J. A., Averna, M., Borén, J., Bruckert, E., Catapano, A. L., Descamps, O. S., et al. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70191-8 · Cited by 635 · see citing works
Familial Hypercholesterolemia: Screening, diagnosis and management of pediatric and adult patients
Goldberg, A. C., Hopkins, P. N., Toth, P. P., Ballantyne, C. M., Rader, D. J., Robinson, J. G., Daniels, S. R., Gidding, S. S., de Ferranti, S. D., Ito, M. K., et al. (2011) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2011.04.003 · Cited by 545 · see citing works
Shepherd, J., Barter, P., Carmena, R., Deedwania, P., Fruchart, J.-C., Haffner, S., Hsia, J., Breazna, A., LaRosa, J., Grundy, S., et al. (2006) · Diabetes Care · doi:10.2337/dc05-2465 · Cited by 525 · see citing works
Kutner, J. S., Blatchford, P. J., Taylor, D. H., Ritchie, C. S., Bull, J. H., Fairclough, D. L., Hanson, L. C., LeBlanc, T. W., Samsa, G. P., Wolf, S., et al. (2015) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2015.0289 · Cited by 502 · see citing works
Gagné, C., Bays, H. E., Weiss, S. R., Mata, P., Quinto, K., Melino, M. R., Cho, M., Musliner, T. A., & Gumbiner, B. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02774-1 · Cited by 494 · see citing works
Kamanna, V. S., & Kashyap, M. L. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.02.029 · Cited by 453 · see citing works
Santos, R. D., Gidding, S. S., Hegele, R. A., Cuchel, M., Barter, P. J., Watts, G. F., Baum, S. J., Catapano, A. L., Chapman, M. J., Defesche, J. C., et al. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)30041-9 · Cited by 423 · see citing works
Knopp, R. H. (2003) · European Heart Journal · doi:10.1016/s0195-668x(02)00807-2 · Cited by 401 · see citing works
Dujovne, C. A., Ettinger, M. P., McNeer, J. F., Lipka, L., LeBeaut, A., Suresh, R., Yang, B., & Veltri, E. P. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02798-4 · Cited by 390 · see citing works
Banach, M., Rizzo, M., Toth, P. P., Farnier, M., Davidson, M. H., Al‐Rasadi, K., Aronow, W. S., Athyros, V. G., Djuric, D. M., Владиславович, Е. М., et al. (2015) · Archives of Medical Science · doi:10.5114/aoms.2015.49807 · Cited by 381 · see citing works
Self-citationWatts, G. F., Gidding, S. S., Wierzbicki, A. S., Toth, P. P., Rodrigo Alonso, K., Brown, W. V., Bruckert, É., Defesche, J. C., Lin, K. K., Livingston, M., et al. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.11.025 · Cited by 377 · see citing works
An Assessment of Statin Safety by Hepatologists
Cohen, D. E., Anania, F. A., & Chalasani, N. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.12.014 · Cited by 354 · see citing works
Bays, H. E., Moore, P. B., Drehobl, M., Rosenblatt, S., Toth, P. D., Dujovne, C. A., Knopp, R. H., Lipka, L., LeBeaut, A., Yang, B., et al. (2001) · Clinical Therapeutics · doi:10.1016/s0149-2918(01)80102-8 · Cited by 312 · see citing works
Cardiovascular morbidity in psoriatic arthritis
Gladman, D. D., Ang, M., Su, L., Tom, B. D. M., Schentag, C. T., & Farewell, V. T. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.094839 · Cited by 304 · see citing works
Bruckert, E., Labreuche, J., & Amarenco, P. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.12.023 · Cited by 273 · see citing works
Recommendations for the use of LDL apheresis
Thompson, G. R. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.02.009 · Cited by 270 · see citing works
Glynn, R. J., Koenig, W., Nordestgaard, B. G., Shepherd, J., & Ridker, P. M. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-152-8-201004200-00005 · Cited by 252 · see citing works
Colhoun, H. M., Betteridge, D. J., & Durrington, P. (2004) · ACC Current Journal Review · doi:10.1016/j.accreview.2004.10.017 · Cited by 233 · see citing works
Hunt, D., Young, P., Simes, J., Hague, W., Mann, S., Owensby, D., Lane, G., Tonkin, A., & for the LIPID Investigators (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-10-200105150-00007 · Cited by 226 · see citing works
Ridker, P. M., Mora, S., & Rose, L. M. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw046 · Cited by 222 · see citing works
Banach, M., Șerban, M.-C., Sahebkar, A., Mikhailidis, D. P., Ursoniu, S., Ray, K. K., Rysz, J., Toth, P. P., Muntner, P., Moșteoru, S., et al. (2015) · BMC Medicine · doi:10.1186/s12916-015-0459-4 · Cited by 215 · see citing works
Self-citationDysfunctional HDL: A novel important diagnostic and therapeutic target in cardiovascular disease?
Otocka-Kmiecik, A., Mikhailidis, D. P., Nicholls, S. J., Davidson, M. H., Rysz, J., & Banach, M. (2012) · Progress in Lipid Research · doi:10.1016/j.plipres.2012.03.003 · Cited by 205 · see citing works
Self-citationLipid-lowering for peripheral arterial disease of the lower limb
Aung, P. P., Maxwell, H., Jepson, R. G., Price, J. F., & Leng, G. C. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000123.pub2 · Cited by 205 · see citing works
Statin non-adherence and residual cardiovascular risk: There is need for substantial improvement
Banach, M., Stulc, T., Dent, R., & Toth, P. P. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.09.075 · Cited by 197 · see citing works
Self-citationBallantyne, C. M., Weiss, R., Moccetti, T., Vogt, A., Eber, B., Sosef, F., & Duffield, E. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.10.022 · Cited by 196 · see citing works
Lipid-modifying effects of nutraceuticals: An evidence-based approach
Sahebkar, A., Șerban, M.-C., Gluba-Brzózka, A., Mikhailidis, D. P., Cicero, A. F. G., Rysz, J., & Banach, M. (2016) · Nutrition · doi:10.1016/j.nut.2016.04.007 · Cited by 188 · see citing works
Self-citationFamilial hypercholesterolaemia: A global call to arms
Vallejo‐Vaz, A. J., Seshasai, S. R. K., Cole, D., Hovingh, G. K., Kastelein, J. J. P., Mata, P., Raal, F. J., Santos, R. D., Soran, H., Watts, G. F., et al. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.09.021 · Cited by 177 · see citing works
Self-citationGuidelines for the Management of Familial Hypercholesterolemia
Harada‐Shiba, M., Arai, H., Oikawa, S., Ohta, T., Okada, T., Okamura, T., Nohara, A., Bujo, H., Yokote, K., Wakatsuki, A., et al. (2012) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.14621 · Cited by 176 · see citing works
Residual macrovascular risk in 2013: what have we learned?
(R3i), F. T. R. R. R. I., Fruchart, J., Davignon, J., Hermans, M. P., Al-Rubeaan, K. A., Amarenco, P., Assmann, G., Barter, P. J., Betteridge, J. D., Bruckert, É., et al. (2014) · Cardiovascular Diabetology · doi:10.1186/1475-2840-13-26 · Cited by 173 · see citing works
Quispe, R., Manalac, R. J., Faridi, K. F., Blaha, M. J., Toth, P. P., Kulkarni, K. R., Nasir, K., Virani, S. S., Banach, M., Blumenthal, R. S., et al. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.06.057 · Cited by 172 · see citing works
Self-citationMichalska, M., Sahebkar, A., Mikhailidis, D. P., Rysz, J., Muntner, P., Toth, P. P., Jones, S. R., Rizzo, M., Hovingh, G. K., Farnier, M., et al. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.10.118 · Cited by 171 · see citing works
Self-citationWatts, G. F., Gidding, S. S., Wierzbicki, A. S., Toth, P. P., Rodrigo Alonso, K., Brown, W. V., Bruckert, É., Defesche, J. C., Lin, K. K., Livingston, M., et al. (2014) · Journal of clinical lipidology · doi:10.1016/j.jacl.2014.01.002 · Cited by 163 · see citing works
Banach, M., Rizzo, M., Toth, P. P., Farnier, M., Davidson, M. H., Al-Rasadi, K., Aronow, W. S., Athyros, V., Djuric, D. M., Ezhov, M. V., et al. (2015) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2015.1039980 · Cited by 162 · see citing works
Self-citationPreiss, D., Campbell, R. T., Murray, H. M., Ford, I., Packard, C. J., Sattar, N., Rahimi, K., Colhoun, H. M., Waters, D. D., LaRosa, J. C., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv072 · Cited by 160 · see citing works
Statins, cognition, and dementia-systematic review and methodological commentary
Power, M. C., Weuve, J., Sharrett, A. R., Blacker, D., & Gottesman, R. F. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2015.35 · Cited by 150 · see citing works
Liao, K. P., Playford, M. P., Frits, M. L., Coblyn, J. S., Iannaccone, C. K., Weinblatt, M. E., Shadick, N. A., & Mehta, N. N. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.114.001588 · Cited by 145 · see citing works
Association between LDL-C and Risk of Myocardial Infarction in CKD
Tonelli, M. A., Muntner, P., Lloyd, A. M., Manns, B., Klarenbach, S. W., Pannu, N., James, M. T., & Hemmelgarn, B. R. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012080870 · Cited by 140 · see citing works
Ito, M. K., McGowan, M. P., & Moriarty, P. M. (2011) · Journal of clinical lipidology · doi:10.1016/j.jacl.2011.04.001 · Cited by 137 · see citing works
Lipid Research Clinics Coronary Primary Prevention Trial Results
Virkkunen, M. (1985) · JAMA · doi:10.1001/jama.1985.03350290037018 · Cited by 136 · see citing works
Simon, J. S., Karnoub, M., Devlin, D. J., Arreaza, M. G., Qiu, P., Monks, S. A., Severino, M. E., Deutsch, P., Palmisano, J. J., Sachs, A. B., et al. (2005) · Genomics · doi:10.1016/j.ygeno.2005.08.007 · Cited by 125 · see citing works
Goldberg, R. B., Guyton, J. R., Mazzone, T., Weinstock, R. S., Polis, A. B., Edwards, P., Tomassini, J. E., & Tershakovec, A. M. (2006) · Mayo Clinic Proceedings · doi:10.4065/81.12.1579 · Cited by 121 · see citing works
Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy
(2012) · New England Journal of Medicine · doi:10.1056/nejmx120034 · Cited by 112 · see citing works
Chapman, M. J., Ginsberg, H. N., Amarenco, P., Andreotti, F., Borén, J., Catapano, A. L., Descamps, O. S., Fisher, E. A. A., Kovanen, P. T., Kuivenhoven, J. A., et al. (2011) · Atherosclerosis Supplements · doi:10.1016/s1567-5688(11)70033-2 · Cited by 105 · see citing works
Association of Serum Lipids and Coronary Heart Disease in Contemporary Observational Studies
Colantonio, L. D., Bittner, V., Reynolds, K., Levitan, E. B., Rosenson, R. S., Banach, M., Kent, S. T., Derose, S. F., Zhou, H., Safford, M. M., et al. (2016) · Circulation · doi:10.1161/circulationaha.115.011646 · Cited by 105 · see citing works
Self-citationBays, H. E. (2002) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.11.11.1587 · Cited by 101 · see citing works
Lipids, blood pressure and kidney update 2014
Banach, M., Aronow, W. S., Șerban, M.-C., Sahabkar, A., Rysz, J., Voroneanu, L. E., & Covic, A. C. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.03.009 · Cited by 92 · see citing works
Self-citationManagement of residual risk after statin therapy
Reith, C. A., & Armitage, J. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.12.018 · Cited by 91 · see citing works
KONES, R. J. (2013) · Vascular Health and Risk Management · doi:10.2147/vhrm.s37119 · Cited by 89 · see citing works
Muntean, D. M., Thompson, P. D., Catapano, A. L., Stasiolek, M., Fabis, J., Muntner, P., Serban, M.-C., & Banach, M. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2016.09.001 · Cited by 82 · see citing works
Gazi, I. F., Daskalopoulou, S. S., Nair, D. R., & Mikhailidis, D. P. (2007) · Current Medical Research and Opinion · doi:10.1185/030079907x226267 · Cited by 80 · see citing works
Lipid, blood pressure and kidney update 2013
Banach, M., Serban, C., Aronow, W. S., Rysz, J., Dragan, S. R., Lerma, E. V., Apetrii, M., & Covic, A. C. (2014) · International Urology and Nephrology · doi:10.1007/s11255-014-0657-6 · Cited by 77 · see citing works
Self-citationMajor Lipids, Apolipoproteins, and Risk of Vascular Disease
Moneta, G. L. (2010) · Yearbook of Vascular Surgery · doi:10.1016/s0749-4041(10)79320-9 · Cited by 77 · see citing works
Prevalence of lipid abnormalities in Poland. The NATPOL 2011 survey
Zdrojewski, T. R., Solnica, B., Cybulska, B., Bandosz, P., Rutkowski, M., Stokwiszewski, J., Gaciong, Z. A., Banach, M., Wojtyniak, B., Pencina, M. J., et al. (2016) · Kardiologia Polska · doi:10.5603/kp.2016.0029 · Cited by 77 · see citing works
Self-citationLipid and Lipoprotein Levels and Trend in Rheumatoid Arthritis Compared to the General Population
Liao, K. P., Cai, T., Gainer, V. S., et al. (2013) · Arthritis Care & Research · doi:10.1002/acr.22091 · Cited by 76 · see citing works
Hobbs, F. R., Banach, M., Mikhailidis, D. P., Malhotra, A., & Capewell, S. (2016) · BMC Medicine · doi:10.1186/s12916-016-0550-5 · Cited by 76 · see citing works
Self-citationStatin use and risk of hepatocellular carcinoma
Lai, S., Liao, K.-F., Lai, H., Muo, C., Sung, F.-C., & Chen, P. (2013) · European Journal of Epidemiology · doi:10.1007/s10654-013-9806-y · Cited by 75 · see citing works
Molecular mechanisms of statin intolerance
Gluba-Brzózka, A., Franczyk, B., Toth, P. P., Rysz, J., & Banach, M. (2016) · Archives of Medical Science · doi:10.5114/aoms.2016.59938 · Cited by 73 · see citing works
Self-citationLipoprotein apheresis: State of the art and novelties
Stefanutti, C., & Julius, U. (2013) · Atherosclerosis Supplements · doi:10.1016/j.atherosclerosissup.2012.10.021 · Cited by 72 · see citing works
Review of Clinical Practice Guidelines for the Management of LDL-Related Risk
Morris, P. B., Ballantyne, C. M., Birtcher, K. K., Dunn, S. P., & Urbina, E. M. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.05.015 · Cited by 68 · see citing works
Should low high-density lipoprotein cholesterol (HDL-C) be treated?
Toth, P. P., Barylski, M., Nikolić, D., Rizzo, M., Montalto, G., & Banach, M. (2013) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2013.11.002 · Cited by 67 · see citing works
Self-citationPająk, A., Szafraniec, K., Polak, M., et al. (2016) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.3464 · Cited by 66 · see citing works
Intensive LDL-cholesterol lowering therapy and neurocognitive function
Banach, M., Rizzo, M., Nikolić, D., Howard, G., Howard, V. J., & Mikhailidis (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.11.001 · Cited by 66 · see citing works
Self-citationRobinson, J. G., Ballantyne, C. M., Grundy, S. M., Hsueh, W. A., Parving, H., Rosen, J. B., Adewale, A. J., Polis, A. B., Tomassini, J. E., & Tershakovec, A. M. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.05.003 · Cited by 64 · see citing works
What is the association of lipid levels and incident stroke?
Glasser, S. P., Mosher, A., Howard, G., & Banach, M. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.06.091 · Cited by 64 · see citing works
Self-citationManagement of fertility in women with familial hypercholesterolaemia: summary of NICE guidance
Thorogood, M., Seed, M., Mott, K. D., & Guideline Development Group (2009) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2008.02084.x · Cited by 63 · see citing works
Meta-Analysis of the Effect of Statins on Mortality in Patients With Preserved Ejection Fraction
Liu, G., Zheng, X., Xu, Y.-L., Ru, J., Hui, R., & Huang, X. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.12.023 · Cited by 63 · see citing works
Rosuvastatin in Older Patients with Systolic Heart Failure
Florkowski, C. M., Molyneux, S. L., & George, P. M. (2008) · New England Journal of Medicine · doi:10.1056/nejmc073536 · Cited by 63 · see citing works
Gränsbo, K., Melander, O., Wallentin, L., Lindbäck, J., Stenestrand, U., Carlsson, J., & Nilsson, J. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.01.013 · Cited by 62 · see citing works
Mikhailidis, D. P., Wierzbicki, A. S., Daskalopoulou, S. S., Al-Saady, N. M., Griffiths, H. R., Hamilton, G., Monkman, D., Patel, V., Pittard, J., & Schächter, M. (2005) · Current Medical Research and Opinion · doi:10.1185/030079905x48447 · Cited by 62 · see citing works
Howard, W. J. (2008) · Yearbook of Endocrinology · doi:10.1016/s0084-3741(08)79121-2 · Cited by 62 · see citing works
Sahebkar, A., Șerban, M.-C., Mikhailidis, D. P., Toth, P. P., Muntner, P., Ursoniu, S., Mosterou, S., Glasser, S. P., Martin, S. S., Jones, S. R., et al. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.12.001 · Cited by 61 · see citing works
Self-citationProprotein Convertase Subtilisin/Kexin 9 Inhibitors
Dragan, S. R., Șerban, M.-C., & Banach, M. (2014) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248414539562 · Cited by 57 · see citing works
Self-citationPCSK9 Inhibition - A Novel Mechanism to Treat Lipid Disorders?
Banach, M., Rizzo, M., Obradovic, M. M., Montalto, G., Rysz, J., Mikhailidis, D. P., & Isenović, E. R. (2013) · Current Pharmaceutical Design · doi:10.2174/13816128113199990303 · Cited by 57 · see citing works
Self-citationLipids, blood pressure and kidney update 2015
Banach, M., Aronow, W. S., Șerban, M.-C., Rysz, J., Voroneanu, L. E., & Covic, A. C. (2015) · Lipids in Health and Disease · doi:10.1186/s12944-015-0169-0 · Cited by 57 · see citing works
Self-citationBooth, J. N., Colantonio, L. D., Howard, G., Safford, M. M., Banach, M., Reynolds, K., Cushman, M., & Muntner, P. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.01.001 · Cited by 57 · see citing works
Self-citationDiscussion around statin discontinuation in older adults and patients with wasting diseases
Banach, M., & Serban, M. (2016) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12109 · Cited by 56 · see citing works
Zdrojewski, T. R., Jankowski, P., Bandosz, P., Bartuś, S., Chwojnicki, K., Drygas, W., Gaciong, Z. A., Hoffmań, P., Kalarus, Z. F., Kaźmierczak, J., et al. (2015) · Kardiologia Polska · doi:10.5603/kp.2015.0182 · Cited by 55 · see citing works
Self-citationHospitalizations for coronary artery disease among patients with systemic lupus erythematosus
Thorburn, C. M., & Ward, M. M. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11241 · Cited by 54 · see citing works
Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
Toth, P. P. (2010) · Yearbook of Endocrinology · doi:10.1016/s0084-3741(10)79553-6 · Cited by 54 · see citing works
Dilemmas in treatment of women with familial hypercholesterolaemia during pregnancy.
Kusters, D. M., Homsma, S. J. M., Hutten, B. A., Twickler, M., Avis, H. J., van der Post, J., & Stroes, E. S. G. (2010) · PubMed · Cited by 52 · see citing works
Avis, H. J., Hutten, B. A., Twickler, T. B., Kastelein, J. J. P., van der Post, J., Stalenhoef, A. F. H., & Vissers, M. N. (2009) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3283319127 · Cited by 52 · see citing works
Kotani, K., Șerban, M.-C., Penson, P. E., Lippi, G., & Banach, M. (2016) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2016.1188055 · Cited by 50 · see citing works
Self-citationExpert opinion: the therapeutic challenges faced by statin intolerance
Patel, J., Martin, S. S., & Banach, M. (2016) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2016.1197202 · Cited by 50 · see citing works
Self-citationPająk, A., Szafraniec, K., Polak, M., Drygas, W., Piotrowski, W., Zdrojewski, T. R., & Jankowski, P. (2016) · Archives of Medical Science · doi:10.5114/aoms.2016.59700 · Cited by 48 · see citing works
Self-citationETC-1002: A future option for lipid disorders?
Nikolić, D., Mikhailidis, D. P., Davidson, M. H., et al. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.10.099 · Cited by 47 · see citing works
Șerban, M.-C., Banach, M., & Mikhailidis, D. P. (2015) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2016.1118055 · Cited by 44 · see citing works
Self-citationLipoprotein (a)—We Know So Much Yet Still Have Much to Learn …
Banach, M. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.116.003597 · Cited by 44 · see citing works
Self-citationSwetz, K. M., Blatchford, P. J., Currow, D. C., et al. (2020) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/0mms-1552 · Cited by 44 · see citing works
Canada's physical activity guides: has their release had an impact?
Cameron, C., Craig, C. L., Bull, F., & Bauman, A. E. (2007) · PubMed · Cited by 43 · see citing works
A review of guidelines for dyslipidemia in children and adolescents.
Peterson, A. L. H., & McBride, P. E. (2012) · PubMed · Cited by 42 · see citing works
LDL-apheresis with dextran sulphate and anaphylactoid reactions to ACE inhibitors
Keller, C., Grützmacher, P., Bahr, F., et al. (1993) · The Lancet · doi:10.1016/0140-6736(93)92542-2 · Cited by 41 · see citing works
Role of lipid apheresis in changing times
Schuff‐Werner, P., Fenger, S., & Kohlschein, P. (2012) · Clinical Research in Cardiology Supplements · doi:10.1007/s11789-012-0049-3 · Cited by 41 · see citing works
Practice setting and secondary prevention of coronary artery disease
Jankowski, P., Czarnecka, D., Badacz, L., Bogacki, P., Dubiel, J. S., Grodecki, J., Grodzicki, T. K., Maciejewicz, J., Mirek-Bryniarska, E., Nessler, J. M., et al. (2017) · Archives of Medical Science · doi:10.5114/aoms.2017.65236 · Cited by 40 · see citing works
Self-citationColesevelam for type 2 diabetes mellitus: an abridged Cochrane review
Ooi, C. P., & Loke, S. C. (2014) · Diabetic Medicine · doi:10.1111/dme.12295 · Cited by 39 · see citing works
Primary prevention of cardiovascular disease with statins in the elderly
Reiner, Ž. (2014) · Current Atherosclerosis Reports · doi:10.1007/s11883-014-0420-6 · Cited by 38 · see citing works
Kaess, B. M., Jozwiak, J. J., Mastej, M., Lukas, W., Grzeszczak, W., Windak, A., Piwowarska, W., Tykarski, A., Konduracka, E., Rygiel, K., et al. (2009) · Heart · doi:10.1136/hrt.2009.171520 · Cited by 38 · see citing works
Self-citationBroncel, M., Gorzelak‐Pabiś, P., Sahebkar, A., Serejko-Banaś, K. E., Ursoniu, S., Rysz, J., Serban, M. C., Możdżan, M., & Banach, M. (2015) · PubMed Central · doi:10.5114/aoms.2015.54841 · Cited by 37 · see citing works
Self-citationChao, T., Liu, C.-J., Chen, S., Wang, K.-L., Lin, Y.-J., Chang, S., Lo, L.-W., Hu, Y.-F., Tuan, T.-C., Chen, T.-J., et al. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.05.159 · Cited by 36 · see citing works
Myśliwiec, M., Walczak, M., Małecka‐Tendera, E., Dobrzańska, A., Cybulska, B., Filipiak, K. J., Mazur, A., Jarosz-Chobot, P. A., Szadkowska, A., Rynkiewicz, A., et al. (2014) · Journal of clinical lipidology · doi:10.1016/j.jacl.2014.01.001 · Cited by 36 · see citing works
Self-citationAn evaluation of RVX-208 for the treatment of atherosclerosis
Nikolić, D., Rizzo, M., Mikhailidis, D. P., Wong, N. C. W., & Banach, M. (2015) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2015.1083010 · Cited by 35 · see citing works
Self-citationKim, M. C., Cho, J. Y., Jeong, H. C., Lee, K. H., Park, K. H., Sim, D. S., Yoon, N. S., Yoon, H. J., Kim, K. H., Hong, Y. J., et al. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2014.09.039 · Cited by 32 · see citing works
Rynkiewicz, A., Cybulska, B., Banach, M., Filipiak, K. J., Guzik, T. J., Idzior−Waluś, B., Imiela, J., Jankowski, P., Kłosiewicz−Latoszek, L., Limon, J., et al. (2013) · Journal of clinical lipidology · doi:10.1016/j.jacl.2013.01.005 · Cited by 31 · see citing works
Self-citationStatins and New-Onset Diabetes
Barylski, M., Nikolić, D., Banach, M., Toth, P. P., Montalto, G., & Rizzo, M. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113196660678 · Cited by 30 · see citing works
Self-citationLipid Metabolism and Cardiovascular Risk in HIV-1 Infection and HAART: Present and Future Problems
Melzi, S., Carenzi, L., Cossu, M. V., Passerini, S., Capetti, A. F., & Rizzardini, G. (2010) · Cholesterol · doi:10.1155/2010/271504 · Cited by 27 · see citing works
Simvastatin with or without Ezetimibe in Familial Hypercholesterolemia
Davis, H. R., Murgolo, N., & Graziano, M. P. (2008) · New England Journal of Medicine · doi:10.1056/nejmx080011 · Cited by 26 · see citing works
He, L., Wickremasingha, P., Lee, J., Tao, B., Mendell-Harary, J., Walker, J., & Wight, D. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.12.033 · Cited by 25 · see citing works
Rysz-Górzyńska, M., & Banach, M. (2016) · Archives of Medical Science · doi:10.5114/aoms.2016.60971 · Cited by 25 · see citing works
Self-citationThe safety of statins in children
Lamaida, N., Capuano, E., Pinto, L., Capuano, E., Capuano, R., & Capuano, V. (2013) · Acta Paediatrica · doi:10.1111/apa.12280 · Cited by 24 · see citing works
Predicting the Risk of Cardiovascular Comorbidities in Adult Cancer Survivors
Tashakkor, A. Y., Moghaddamjou, A., Chen, L. Y. C., & Cheung, W. Y. (2013) · Current Oncology · doi:10.3747/co.20.1470 · Cited by 23 · see citing works
PPAR Agonists, Atherogenic Dyslipidemia and Cardiovascular Risk
Nikolić, D., Castellino, G., Banach, M., et al. (2016) · Current Pharmaceutical Design · doi:10.2174/1381612822666161006151134 · Cited by 20 · see citing works
Self-citationKaess, B. M., Jozwiak, J. J., Nelson, C. P., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086837 · Cited by 19 · see citing works
Banach, M., Nikolić, D., Rizzo, M., & Toth, P. P. (2016) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000305 · Cited by 19 · see citing works
Self-citation(1992) · Archives of Internal Medicine · doi:10.1001/archinte.152.7.1399 · Cited by 19 · see citing works
Hunt, D., Young, P., & Simes, J. R. (2001) · ACC Current Journal Review · doi:10.1016/s1062-1458(01)00463-9 · Cited by 17 · see citing works
The Lipid Research Clinics Coronary Primary Prevention Trial
L'Abbé, K. A. (1985) · JAMA · doi:10.1001/jama.1985.03350450063008 · Cited by 17 · see citing works
Preiss, D., Campbell, R. T., Murray, H. M., Ford, I., Packard, C. J., Sattar, N. A., & McMurray, J. J. V. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.04.086 · Cited by 17 · see citing works
Tomasik, T., Jozwiak, J. J., Windak, A., Rygiel, K., Mastej, M., Smithson, W. H., Mathers, N. J., Tomaszewski, M., Kaess, B. M., Tykarski, A., et al. (2011) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1177/1741826710389366 · Cited by 16 · see citing works
Self-citationBays, H. E. (2001) · Clinical Therapeutics · doi:10.1016/s0149-2918(01)80131-4 · Cited by 16 · see citing works
Pająk, A., Jankowski, P., Kawecka−Jaszcz, K., Surowiec, S., Wolfshaut–Wolak, R., Loster, M., Batko, K., Badacz, L., Dubiel, J. S., Grodecki, J., et al. (2009) · PubMed · Cited by 15 · see citing works
Self-citationRysz, J., Gluba-Brzózka, A., Banach, M., & Więcek, A. (2015) · International Urology and Nephrology · doi:10.1007/s11255-015-0937-9 · Cited by 14 · see citing works
Self-citationDeo, S. V., Rababa’h, A. M., Altarabsheh, S. E., Lim, J. Y., Cho, Y. H., & Park, S. J. (2014) · Heart Lung and Circulation · doi:10.1016/j.hlc.2014.04.007 · Cited by 12 · see citing works
Wożakowska−Kapłon, B., Filipiak, K. J., Mamcarz, A., et al. (2014) · Kardiologia Polska · doi:10.5603/kp.2014.0182 · Cited by 12 · see citing works
Self-citationKnopp, R. H., Gitter, H., & Truit, T. (2003) · ACC Current Journal Review · doi:10.1016/s1062-1458(03)00279-4 · Cited by 11 · see citing works
Pająk, A., Wiercińska, E., Polakowska, M., et al. (2005) · PubMed · Cited by 11 · see citing works
Jankowski, P., Czarnecka, D., Łukaszewska, A., et al. (2016) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.3447 · Cited by 11 · see citing works
Self-citationStatin Use is Associated with Better Cognitive Function in Elderly with Type 2 Diabetes
Heymann, A. D., Ravona‐Springer, R., Moshier, E. L., Godbold, J., & Beeri, M. S. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-142571 · Cited by 10 · see citing works
Premature cardiovascular disease in young women with heterozygous familial hypercholesterolemia
van der Graaf, A., Hutten, B. A., Kastelein, J. J. P., & Vissers, M. N. (2006) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.4.3.345 · Cited by 7 · see citing works
Rynkiewicz, A., Cybulska, B., Banach, M., et al. (2013) · PubMed · Cited by 6 · see citing works
Self-citationŚliż, D., Filipiak, K. J., Naruszewicz, M., Siebert, J., & Mamcarz, A. (2015) · Annals of Agricultural and Environmental Medicine · doi:10.5604/12321966.1196865 · Cited by 5 · see citing works
Self-citation[Prevention of atherosclerosis in children--the role of statins and aspirin].
Stolarz‐Skrzypek, K., Bednarski, A., Drożdż, D., et al. (2013) · PubMed · Cited by 4 · see citing works
Reiner, Ž. (2015) · Kardiologia Polska · doi:10.5603/kp.2015.0121 · Cited by 4 · see citing works
Colesevelam for Type 2 diabetes mellitus: an abridged Cochrane review
Elkeles, R. S. (2014) · Diabetic Medicine · doi:10.1111/dme.12424 · Cited by 3 · see citing works
The pharmacokinetic of drugs in elderly patients
Jabłecka, A., Korzeniowska, K. A., & Smolarek, I. (2008) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.568 · Cited by 3 · see citing works
Konduracka, E., Jozwiak, J. J., Mastej, M., Lukas, W., Tykarski, A., Szczepaniak‐Chicheł, L., & Piwowarska, W. (2008) · PubMed · Cited by 3 · see citing works
Tendera, M., Kozakiewicz, K., Bartnik, M., et al. (2001) · PubMed · Cited by 2 · see citing works
Flagged first, then by citations
Research works printed but not linked: 2
- [12]Pająk A Wiercińska E Polakowska M Rozpowszechnienie dyslipidemii u mężczyzn i kobiet w wieku 20–74 lat w Polsce. Wyniki programu WOBASZ Kardiol Pol 2005 63 Suppl. 4 620 6 20527433
- [112]Rynkiewicz A Cybulska B Banach M Postępowanie w heterozygotycznej hipercholesterolemii rodzinnej. Stanowisko Forum Ekspertów Lipidowych Kardiol Pol 2013 71 107 11 23348551
Cited by
Sorted by citations
Cicero, A. F. G., Colletti, A., Bajraktari, G., Descamps, O., Djuric, D. M., Ezhov, M., Fras, Z., Katsiki, N., Langlois, M., Latkovskis, G., et al. (2017) · Archives of Medical Science · doi:10.5114/aoms.2017.69326 · Cited by 281 · see citing works
Self-citationThe Role of Nutraceuticals in Statin Intolerant Patients
Banach, M., Patti, A. M., Giglio, R. V., Cicero, A. F. G., Atanasov, A. G., Bajraktari, G., Bruckert, E., Descamps, O., Djuric, D. M., Ezhov, M., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.04.040 · Cited by 272 · see citing works
Self-citation
- Authors
- Banach, M., Jankowski, P., Jóźwiak, J., Cybulska, B., Windak, A., Guzik, T., Mamcarz, A., Broncel, M., & Tomasik, T.
- Affiliations
- Medical University of Lodz (PL)
- Jagiellonian University (PL)
- Instytut Zywnosci Zywienia (PL)
- Medical University of Warsaw (PL)
- Corresponding author
- Banach, Maciej
- ORCID
- Venue
- Archives of Medical Science
- Publisher
- Termedia Sp. z.o.o.
- Published
- 2017
- Volume
- 1
- Issue
- 1
- Pages
- 1-45
- ISSN
- 1734-1922 (ISSN-L)
- PMC
- PMC5206369
- OpenAlex
- W2587144586
- Cited by
- 86
- References
- 175
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 5 · 2023: 7 · 2022: 4 · 2021: 8 · 2020: 15 · 2019: 14 · 2018: 16 · 2017: 12 · 2013: 1
- FWCI
- 15.97
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-sa
- Locations
- Archives of Medical Science (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Homo Politicus (Academy of Humanities and Economics in Lodz) (submittedVersion, cc-by-nc-nd)
- Jagiellonian University Repository (Jagiellonian University) (submittedVersion, cc-by-nc-nd)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
- Keywords
- dyslipidemia, dyslipidemia management, cardiovascular risk factors, general practitioners, cardiovascular disease prevention, atherosclerosis, ischemic heart disease, stroke, peripheral arterial disease, modifiable risk factors, sedentary lifestyle, dietary habits
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
